According to Lipocine's latest financial reports the company's current EPS (TTM) is -$3.69. In 2022 the company made an earnings per share (EPS) of -$3.39 a decrease over its 2021 EPS that were of -$0.28.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.63 | 7.2% |
2022 | -$3.39 | 1094.12% |
2021 | -$0.28 | -97.5% |
2020 | -$11.34 | -20% |
2019 | -$14.18 | -9.09% |
2018 | -$15.59 | -47.12% |
2017 | -$29.48 | -0% |
2016 | -$29.48 | -4.93% |
2015 | -$31.02 | -31.63% |
2014 | -$45.36 | 74.47% |
2013 | -$26.00 | -99.35% |
2012 | -$3,989 |